Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents

Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents

Dual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical, immunological, and virological features from single infection with HCV or HBV, which brings various challenges to clinical diagnosis/treatment and management. Direct-acting antiviral agents...

Full description

Bibliographic Details
Main Author: YU Yuecheng
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2018-02-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=8808
id doaj-7385428b2d22405f9caf9301e05594bb
record_format Article
spelling doaj-7385428b2d22405f9caf9301e05594bb2020-11-24T23:40:47ZzhoEditorial Department of Journal of Clinical HepatologyLinchuang Gandanbing Zazhi1001-52561001-52562018-02-0134223824110.3969/j.issn.1001-5256.2018.02.004Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agentsYU Yuecheng0Liver Disease Center of PLA, Bayi Hospital, Nanjing University of Chinese Medicine, Nanjing 210002, ChinaDual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical, immunological, and virological features from single infection with HCV or HBV, which brings various challenges to clinical diagnosis/treatment and management. Direct-acting antiviral agents used for effective control of HCV infection may cause HBV activation, onset of hepatitis B, and even liver failure. Therefore, during the antiviral treatment of HCV infection, it is of great importance to select appropriate anti-HBV therapy and follow-up management strategies based on the status of HCV/HBV dual infection. http://www.lcgdbzz.org/qk_content.asp?id=8808
collection DOAJ
language zho
format Article
sources DOAJ
author YU Yuecheng
spellingShingle YU Yuecheng
Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
Linchuang Gandanbing Zazhi
author_facet YU Yuecheng
author_sort YU Yuecheng
title Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
title_short Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
title_full Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
title_fullStr Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
title_full_unstemmed Features and management of patients with hepatitis C virus/hepatitis B virus dual infection associated with the application of direct-acting antiviral agents
title_sort features and management of patients with hepatitis c virus/hepatitis b virus dual infection associated with the application of direct-acting antiviral agents
publisher Editorial Department of Journal of Clinical Hepatology
series Linchuang Gandanbing Zazhi
issn 1001-5256
1001-5256
publishDate 2018-02-01
description Dual infection with hepatitis C virus (HCV) and hepatitis B virus (HBV) has significantly different clinical, immunological, and virological features from single infection with HCV or HBV, which brings various challenges to clinical diagnosis/treatment and management. Direct-acting antiviral agents used for effective control of HCV infection may cause HBV activation, onset of hepatitis B, and even liver failure. Therefore, during the antiviral treatment of HCV infection, it is of great importance to select appropriate anti-HBV therapy and follow-up management strategies based on the status of HCV/HBV dual infection.
url http://www.lcgdbzz.org/qk_content.asp?id=8808
work_keys_str_mv AT yuyuecheng featuresandmanagementofpatientswithhepatitiscvirushepatitisbvirusdualinfectionassociatedwiththeapplicationofdirectactingantiviralagents
_version_ 1725509044673708032

Similar Items